Temasek led an $85 million series B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also participated in the round.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,